Oragenics Inc. has announced the appointment of Ms. Natasha Giordano to its Board of Directors, effective September 1, 2025. Ms. Giordano brings extensive experience in pharmaceutical commercialization and management, having previously held leadership roles at companies such as PLx Pharma Inc., ClearPoint Learning, Inc., and Xanodyne Pharmaceuticals, Inc. She is also currently serving as the Board Chair for Incora Health and holds positions on the Board of Directors for Afaxys Inc. The company has stated that Ms. Giordano will stand for re-election at the next annual shareholder meeting.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Oragenics Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001493152-25-012562), on September 02, 2025, and is solely responsible for the information contained therein.